Belgium: Covid-19 coronavirus: measures to combat medicine shortages extended again

Veerle Pissierssens

Since April 2020, the Belgian government has taken measures to avoid medicine shortages during the Covid-19 pandemic. These measures have subsequently been revised and extended in duration four times. The measures have now been further extended until 28 October 2020 by a Federal Agency for Medicines and Health Products (FAMHP) decision dated 25 September 2020, because the SARS-CoV-2 pandemic experienced a major resurgence in Belgium in September. The number of infections and hospitalisations are rising severely.

The measures are aimed at controlling stocks of medicinal products used in the treatment of Covid-19 patients. The rules on quotas for wholesalers and distribution between hospitals remain in place. The lists of medicinal products and raw materials subject to controlled distribution drawn up by the FAMHP, in Annex I and II to the decision remain unchanged.

The FAMHP is expected to continue to update these measures monthly as the Covid-19 pandemic evolves. Depending on the evolution of the spread of the virus, additional measures may be imposed.

A prior version of this post was originally published by the same authors in Practical Law – Life Sciences, November 2020 Issue (Thomson Reuters).

Share
Read comments below or add a comment
Comments published on the Life Sciences Hub do not necessarily reflect the views of Allen & Overy or its clients.

Leave a comment

Your e-mail address will not be published. Required fields are marked *